PFE performed quite well compared to its peers, and diversified companies like ABT and JNJ did very well too but foreign pharmas really shone. Here is a summary and the figures are approximate (for the last 52 weeks).
BMY rose only 6% and the dividend yield is 4.4%
MRK rose 11% and the yield is 4.2%
JNJ rose 14% and the yield is 3.5%
PFE rose 21% and the yield is 3.9%
ABT rose 22% and the yield is only .9%
NVS rose 24% and the yield is 3.9% like PFE
Roche, the Swiss giant (RHHBY) rose 30% but I am not sure about the dividend if they pay annualy or quarterly?